SAN JUAN CAPISTRANO, Calif., Oct. 10, 2006 (PRIMEZONE) -- American Mold Guard, Inc. (Nasdaq:AMGI), an industry leader in the field of mold prevention services, today announced the addition of Dr. Atif Malik as the Company's Chief Science Officer.
Dr. Atif Malik graduated cum laude with triple majors in Chemistry, Biology and Fine Arts from Houston Baptist University. He went on to complete his residency training at Baylor College of Medicine where he was chosen to be Chief Resident. During his residency he was the recipient of many awards, including the Oliver R. Smith Jr., M.D. award for excellence. Dr. Malik then completed an Interventional Pain Fellowship in the Department of Anesthesia at Harvard Medical School's Beth Israel Deaconess Medical Center in Boston. He has been a member of the International Association for the Study of Pain, American Pain Society, American Medical Association and other professional organizations. Furthermore, he has authored a number of peer reviewed research journal articles, scientific abstracts, reviews, and book chapters. Dr. Malik has had an active schedule that includes practicing clinical medicine, research, professional presentations and lecturing. He served as the former medical director for CPMC Surgery Center and the Acute Pain Director at Shady Grove Adventist Hospital in Rockville, Maryland. Most recently, Dr. Malik started the Advanced Pain & Spine Center in Germantown, Maryland and serves as the Pain Director at Washington Adventist Hospital. Dr. Malik has participated in providing medical relief for Katrina victims and was one of the main organizers of Operation Heart Beat during the October 2005 South Asia earthquake, a charity involved in disaster relief. He was given a presidential letter of recognition by George Bush for his humanitarian efforts. Dr. Malik also sits on the board of directors of several medical corporations and charities.
"We are excited to have Dr. Malik join American Mold Guard as the Chief Science Officer," said Tom Blakeley, CEO of American Mold Guard. "As a respected Physician in Maryland, Dr. Malik brings a wealth of knowledge and industry contacts instrumental towards expanding the company's leadership in antimicrobial surface applications. His experience with hospital acquired infections (HAIs) coupled with American Mold Guard's innovative surface applications in antimicrobial polymer technology, will enable the company to expand its service offerings, using existing operational infrastructure, to help reduce the number of HAIs throughout the United States," concluded Mr. Blakeley.
About American Mold Guard
American Mold Guard, Inc. (Nasdaq:AMGI), founded in 2002, is the industry leader in the field of mold prevention services. Its services are primarily focused on the residential real estate construction industry in California, Texas, Louisiana, Mississippi and Florida; with active expansion throughout the United States. Its customers include many of the largest national and regional home builders. Visit: www.americanmoldguard.com.
Forward-Looking Statements
This press release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 regarding, among other things, statements relating to goals, plans and projections regarding the company's financial position, results of operations, market position, product and service development and market strategy. These statements may be identified by the fact that they use words or phrases such as "anticipates," "believes," "estimates," "expects," "intends," "plans," "predicts," "projects," "targets," "will likely result," "will continue," "may," "could" and other words and terms of similar meaning in connection with any discussion of future operating or financial performance. Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, including factors that could delay, divert or change any of them, and could cause actual outcomes and results to differ materially from current expectations. These factors include, among other things, competitive product and service development, future broad market acceptance of mold prevention services, difficulties in raising additional capital in the future, difficulties and delays in establishing the "Mold Guard" brand, the impact of the absence of significant proprietary technology underlying our services, a continued and long-term dependence on a limited number of customers, changes to the inventory levels of the company's raw materials suppliers, the impact of a continued absence of exclusive or long-term commitments from the company's customers, changes in the anticipated size or trends of the markets in which the company competes, judicial decisions and governmental laws and regulations, and changes in general economic conditions in the markets in which the company may compete. For further details and a discussion of these and other risks and uncertainties, see the company's periodic reports including current reports on Form 8-K, quarterly reports on Form 10-Q and the annual report on Form 10-K, furnished to and filed with the Securities and Exchange Commission. The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.